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Abstract
Guanidinium groups present in peptides and dendritic polymers induce their efficient transport through liposomal and cell membranes. Trans-
membrane crossing of these polymers is affected by their structural features and is critically dependent on the number of guanidinium groups present.
Furthermore, the interaction of the guanidinium groups with phosphate groups, both located on liposomal surfaces, triggers a series of processes
involving a reorganization of the self-assembled lipids and inducing the formation of multicompartment systems. These observations consistent
throughout a diversity of interacting complementary liposomes, support a hypothesis that molecular recognition of liposomes induces the formation of
multicompartment structures.
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The role of molecular transporters [1–4] and in particular of
drug transporters [5–7] in enhancing membrane transport is an
issue of great scientific and practical interest and has recently
been addressed employing either cells or model liposomal sys-
tems. In both cases the role of an appended guanidinium group,
which is the strongest organic base (pKa 13.65) [8], is crucial⁎ Corresponding author. Institute of Physical Chemistry, NCSR “Demokritos”,
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doi:10.1016/j.bbamem.2007.12.003due to its interaction with the phosphate or other anionic moi-
eties on the liposomal or cell surface. This is the first stage in
the process of molecular transporting in which strong binding
between the interacting parties is achieved due to combined
hydrogen-bonding and electrostatic forces (Fig. 1). In this con-
nection, it should be noted that strong binding of guanidinium
to acidic groups is further amplified as the organization of the
interacting substrate is enhanced i.e. as one proceeds from isotropic
conditions to liposomal and finally to macroscopic interfaces [9]
(Fig. 2). These results clearly indicate that molecular recognition is
more effective at interfaces and this binding enhancement is taken
advantage of in the liposomal interactions discussed in this review.
Fig. 1. Complex formed between guanidinium and phosphate groups through
combined electrostatic forces and bidentate hydrogen-bonding.
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porters to guanidinylated poly(propylene imine) dendrimers
[10] or other dendritic polymers has stemmed from the analo-
gous application of arginine-rich peptides [1,2,11] which also
bear a multiplicity of guanidinium moieties. These peptides
proved to exhibit enhanced translocation properties, due to the
presence of an appropriate number of guanidinium groups. On
the other hand, guanidinylated poly(propylene imine) dendri-
mers having the possibility to bear a varying number of gua-
nidinium moieties also exhibit the so-called adaptive solubility
behaviour [12], rendering the dendrimer either hydrophobic or
hydrophilic depending on the environment. This is irrespective
of the anion effect which tunes hydrophobicity in peptides
[13,14]. In the present case, following the binding of the gua-
nidinium to the phosphate groups, guanidinylated dendrimers
lie in close proximity to the membrane while they simulta-
neously adopt a more hydrophobic conformation. This is due to
the fact that the guanidinylated derivatives bound to the lipo-
somal surface become less polar through charge neutralization,
and therefore more prone to enter the hydrophobic bilayer. In
addition to charge neutralization, the adaptive solubility be-
haviour of dendrimers, i.e. “chameleon behaviour”, as for the
first time coined by Paleos et al. [12] begins to function, chang-
ing conformation and exposing their hydrophobic interior toFig. 2. Binding constants of guanidinium and phosphatethe bilayer medium. Due to these processes the guanidinylated
derivatives become appreciably hydrophobic and consequently
appropriate for transport through the hydrophobic liposomal
membrane.
In addition it has recently been established that interaction of
guanidinium and phosphate groups, located on the surfaces
of complementary liposomes, results in the formation of giant
liposomes incorporating inside their interior smaller liposomes
[15]. These structures are reminiscent of the multicompartment
character of eukaryote cells, hypothesized to result from a symbio-
tic association of prokaryotes, which have analogous structures to
unilamellar liposomes [16]. This so-called Serial Endosymbiosis
Theory of Eukaryotic Evolution is supported by studies on mito-
chondria and chloroplasts which are considered to be evolved from
prokaryotes (bacteria) living in large cells [17–19]. Thus, it is
worth exploring this phenomenon associated with molecular re-
cognition of complementary liposomes and formation of multi-
compartment systems. It seems that the role of lipids is crucial,
self-assembling and organizing in membranes which may lead in
the formation of either single compartment prokaryotes or mul-
ticompartment eukaryote cells [20–22].
In fact, it has to be noted that due to the organization of
lipids into liposomal bilayers, the well-established organiza-
tional [9,23,24] and multivalent effects [25,26] are exercised
during liposome interaction and adhesion. These effects are
beneficial in obtaining enhanced initial liposomal or cell bind-
ing as previously mentioned and established by the work of
Kunitake et al. [9,24]. The presence of recognizable groups in
close proximity, at the relatively small external liposomal or cell
surface, induces effective association between the interacting
parties.
In this review we will address two processes, both of which
are triggered by the presence of guanidinium moiety in appro-groups at isotropic and other organized interfaces.
Table 1
Structure of the most extensively studied cell-penetrating peptides
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tides and guanidinylated dendrimers through liposomal and cell
membranes and B. Investigation of multicompartmentalization,
resulting from the interaction of complementary liposomes,
functionalized with phosphate and guanidinium groups respec-
tively. These strategies may probably shed some light to the
extremely complicated process of cell evolution. The experi-
mental indications discussed below together with the proposed
working hypothesis may constitute a starting point for ad-
dressing this issue. On the other hand they certainly lead to the
explanation of practical contemporary problems, such as the
processes involved in the interaction of liposomal drug delivery
systems with cells [27,28].
2. Transport of arginine based peptides through liposomal
and cell membranes
Drug delivery employing macromolecules has been a
research challenge since they initially have to overcome the
cell membrane barrier, which is impermeable to polar molecules
due to its hydrophobic interior. Several natural proteins are
nevertheless able to translocate across the cell membranes, with
the most prominent being Tat49–57, Penetratin and Transportan
[29] (Table 1). These peptides have extensively been studied as
carrier molecules for the delivery of bioactive compounds
to either cells or liposomes. The latter represent a simple, yet
efficient model for studying cell membrane transport of water-
soluble molecules. In both cases interaction of the peptides led to
sufficient internalization. When liposomes with different lipid
composition were employed, internalization of the peptides was
favored for negatively charged lipids incorporated into the lipo-
somal bilayer [30,31].
The common feature of these peptides is that they are pri-
marily comprised of basic amino acids i.e. L-arginine and/orFig. 3. Structure of R(aL-lysine, indicating that there is a relationship between peptides
with high basic amino acid residue content and their ability
to translocate across model liposomal or cell membranes. Further
investigations proved that the translocation properties of these
peptides are directly associated with the presence of L-arginine
residues. In the case of Tat peptide, replacement of L-arginine
residueswith less basic amino acids such as L-lysine, L-ornithine, or
L-histidine has led to reduced translocation ability [32]. On the
contrary replacement of all non-L-arginine residues with L-arginine
resulted in a several-fold enhancement of peptide internaliza-
tion [33]. In order to assess the effect of the L-arginine content on
cellular uptake, studies were carried out by Futaki et al. [34]
employing a series of L-arginine homopolymers bearing 4 to 16
residues. Throughout these experiments, the appropriate number of
L-arginine moieties for optimum uptake was found to be between 7
and 9, since these oligomers exhibited enhanced cell accumulation,
with L-arginine nonamer (R9) being 20-fold more efficient than Tat
peptide. These derivatives were localized on the cytosol and the
nucleus whereas oligomers with 4–6 L-arginine residues were
not internalized in the cells. However oligomers with more than 10
L-arginines were mostly localized on the cell membrane. The same
results were obtained by Wender et al. [33] concerning the cellular
uptake of L-arginine oligomers bearing 5, 6, 7, 8 and 9 L-arginine
residues.
The translocational ability of L-arginine monomer was inves-
tigated to relate to the results regarding synthetic poly-L-arginines.
Membrane transport of L-arginine was studied employing sodium
dihexadecyl phosphate (DHPNa) small unilamellar liposomes; its
transport proved to be dependent on the organization of their
lipid bilayer [35], while transport of poly-L-arginine was studied
employing small unilamellar liposomes consisting of phos-
phatidylcholine (PC), cholesterol (Chol) and DHPNa. Moreover,
fluorescence quenching experiments employing FITC-labeled
poly-L-arginine demonstrated that translocation of the polymer
took place at low guanidinium/phosphate molar ratios and when
the liposomal bilayer is in the liquid crystalline phase [36].
In order to determine the structural requirements for cellular
uptake of short arginine-rich peptides, Wender et al. [37] exa-
mined a series of L-arginine heptamers. For this purpose, ami-
nocaproic acid (aca) was introduced as a spacer between the
L-arginine residues at different structural modes as tabulated
[37]. The results showed the importance of spacing for cellularcaR)5acaR peptide.
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(Fig. 3). The increased distance between the L-arginine residues
resulted in increased conformational freedom of the peptide
backbone. This seems to be necessary for all L-arginine resi-
dues to interact effectively with oppositely charged moieties of
the membrane.
Once the importance of L-arginine was established, research
was focused on the relation between the guanidinium group and
the penetrating ability. Remarkably, guanidinium-rich synthetic
molecules such as oligopeptoids [33] and oligocarbamates [38]
(Fig. 4) demonstrated comparable or even higher translocation
ability with respect to L-arginine nonamer (R9). The parameters
affecting the ability of these compounds to cross cell membrane
were the number of the guanidinium groups along with the dis-
tance between the guanidinium moiety and the oligomer back-
bone. Regarding the number of the guanidiniumgroups, nonamers
were again the most effective. Interestingly, cellular uptake was
improved when the number of alkyl spacer between the gua-
nidinium head group and the backbone was increased from 3
(in the case of L-arginine) to 4 or 6, indicating the importance of
sterical freedom of the side chains which is essential for all the
guanidinium groups to interact with the cell membrane.
A possible mechanistic pathway of cell internalization has
been proposed involving the formation of a non-polar complex
[1,13] between the positively charged guanidinium groups and
the negatively charged species present at the external surface of
the cell membrane. The complex formed has the ability to cross
the hydrophobic interior of the cell membrane and be effectively
internalized. Initial studies [13,39] were carried out involving
the partitioning of oligoarginine/polyarginine in biphasic polar/
non-polar solutions. Specifically, when the highly hydrophilic
guanidinium-rich transporters were introduced to a biphasic so-
lution, i.e. water/chloroform, they were exclusively partitioned in
the aqueous phase. However, addition of an amphiphilic anion,
like phosphatidyl glycerol (PG) or a fatty acid or sodium dodecyl
sulphate (SDS) in the organic layer resulted in almost complete
partition of the guanidinylated transporter in chloroform. On the
contrary hydrophilic polyanions like heparin could not mediateFig. 4. Structure of cell-penetrating molecules: oligocarbamates (left) and
oligopeptoids (right) with x=7–9 and n=3, 4, 6.phase transfer of the oligoarginine transporters into the organic
layer. Interestingly, when the non-polar complexes formed by the
interaction of oligoarginines and amphiphilic anions were dis-
solved in chloroform, the presence of hydrophilic polyanions like
heparin in the aqueous layer resulted in a reverse phase transfer of
the transporter to the aqueous phase through counter ion exchange
[13,14,39].
Advancing a step forward, liposomes were employed as a
more elaborate system for elucidating the translocation mecha-
nism. When large unilamellar liposomes consisting of phospha-
tidylcholine (PC) were employed, oligoarginine/polyarginine
could not translocate across the lipid bilayer. However trans-
location was successful when anionic lipids, i.e. phosphatidyl-
glycerol (PG) were incorporated in the lipid bilayer in a 1:1
molar ratio with respect to PC. The significance of the counter
ion for the formation of the non-polar complex and its sub-
sequent transport across the lipid bilayer was also investigated
employing carboxyfluorescein (CF)-loaded liposomes com-
posed of PC [14]. As already mentioned, these liposomes can-
not mediate oligoarginine/polyarginine translocation. The
presence of molecules that could form a non-polar complex
i.e. pyrene butyrate or coronene butyrate, in the bulk aqueous
phase resulted in an effective transport of the complex across
the lipid bilayer [40]. The oligoarginine/polyarginine was sub-
sequently interacted with the entrapped self-quenched carboxy-
fluorescein molecules and the resulting non-polar complex
was able to cross the liposomal bilayer. Efflux of CF from the
liposomal interior to the bulk aqueous phase was therefore
observed by fluorescence spectroscopy.
All these experiments indicate the significance of a non-polar
complex formation between oligoarginine/polyarginine and
amphiphilic anions for effective transport to the bulk chloroform
layer or across lipid bilayers. The formation of the non-polar
complex is due to the effective interaction of the guanidinium
group of the transporter with the phosphate or carboxylate
groups of the amphiphilic molecules through combined elec-
trostatic interaction and bidentate hydrogen-bonding [1,41].
This behaviour was not observed in the case of oligolysines or
oligoornithines since monodentate hydrogen bonds are formed.
Charge neutralization, however, with membrane constituents
cannot be the only driving force for cellular entry. The presence of
a transmembrane potential, based on the intracellular and extra-
cellular K+ concentration gradient, was considered to have a
crucial role on the accumulation of guanidinium-rich transporters.
This hypothesis was set forth by Wender et al. [41] based on
experiments of cellular uptake of L-arginine octamer (R8), where
themembrane potential was decreased close to zero by incubating
cells with an isotonic buffer (K+PBS). Uptake of R8 was reduced
up to 90% at all concentrations with respect to the uptake ob-
served when the cells were incubated with PBS. The same result
was obtained when the cells were pretreated with a pore-forming
peptide i.e. Gramicidin A, which also decreases the membrane
potential. On the contrary, hyperpolarizaton of the cell membrane
with valinomysin, an antibiotic that selectively shuttles potassium
ions across the membrane, resulted in a significant increase of the
transporter internalization. Throughout these experiments it be-
came clear that charge neutralization of the guanidiniumgroups of
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for effective internalization; however the portion of the inter-
nalized complex is also directly associated with the transmem-
brane potential.
The structural characteristics of Tat peptide and synthetic
guanidinium-richmolecular transporters have implied their use as
transporter molecules for the delivery of bioactive compounds
such as drugs (Taxol, Cyclosporin A), proteins (Luciferin), plas-
mid DNA [42] and even nanoparticles [43,44] such as magne-
tic nanoparticles or liposomes. In one case, modification of
L-arginine heptamer with myristoyl chloride was reported [45] to
facilitate delivery across the brain-blood barrier. Small molecules
delivery requires the presence of an appropriate spacer group
between the transporter and the drug which can be cleaved intra-
cellularly under certain conditions in order to achieve sufficient
drug accumulation. Such transporter-drug conjugates have been
reported bearing either a cysteine-disulfide bond [46] or a hy-
drolysable ester [47] or a pH-sensitive linker [48] for Luciferin,
Taxol and Cyclosporin A conjugates, respectively.
Recent studies have revealed that incorporation of Tat or
oligoarginine-modified lipids into liposomes can lead to en-
hanced cellular uptake of these liposomal formulations or their
protein complexes. It has been reported by Torchilin et al. [44]
that Tat-modified liposomes with a diameter of 200 nm with the
Tat-peptide located either on the liposomal surface or at the
distal end of a poly(ethylene glycol) spacer, were able to trans-
port through cell membranes. Effective uptake of these liposo-
mal formulations by cells required the presence of 500 transporter
molecules per liposome bound on their surface. In the case of
oligoarginine-modified liposomes, the number of L-arginine re-Fig. 5. Schematic representation of a multifunctional dendrimer.
Fig. 6. Structures of branched-chain arginine-rich peptides.sidues was crucial in order to achieve effective cell internalization
of free liposomal formulations and of liposome/protein complexes
[49]. Thus, for liposomes modified with oligoarginines bearing 4,
6, 8, and 10 residues, the shorter oligoarginine led tomore effective
cellular uptake of the protein free liposomes, while for the intra-
cellular delivery of liposome/protein (BSA, β-galactosidase and
immunoglobulin G) complexes, liposomes modified with oligoar-
ginines with 4 and 10 residues gave the best results. Since the
guanidinium group enhances cell penetrating properties, guanidi-
nylated polymers which can convey high drug payloads can be
promising candidates for enhanced cell internalization along with
effective drug delivery.
3. Transport of guanidinylated dendrimers through
liposomal and cell membranes
Dendritic polymers have already been studied and used as
vectors for delivering bioactive compounds into cells [50–53].
The advantages of these systems originate from their nanometer-
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the environment of which determines their solubilizing or en-
capsulating properties, while the external groups primarily cha-
racterize their solubility and chemical behaviour. Due to the
presence of several terminal groups at their surface, a diversity of
functional groups can be introduced leading to the so-called
multifunctional dendrimers (Fig. 5), bearing targeting ligands,
transporting agents and protective coating.
Since the role of the guanidinium group in inducing cell pene-
trating properties has been established, the effect of molecular
architecture on molecular transporters translocation ability was
further investigated. Thus, dendritic polymers, already applied as
drug delivery systems and conveniently subjected to functiona-
lization could be appropriate systems for investigating molecular
transporting properties following their functionalization.
The effect of the dendritic architecture was investigated by
Futaki et al. [54]. Thus dendritic molecules with varying num-
ber of L-arginine residues (from 4 to 24) were synthesized and
their translocation ability was assessed (Fig. 6). The results
demonstrated accumulation of these dendritic molecules into
cells with the most effective being the derivative bearing 8
arginine moieties. As the number of arginine residues was either
decreased or increased, the cellular uptake efficiency was re-
duced. Interestingly, the introduction of a spacer bearing 3 glycine
moieties on the dendrimeric surface rendered the derivative with
24 arginine moieties an efficient transporter. It therefore became
evident that the characteristics which render the linear guani-
dinium oligomers effective transporters are also applicable on
dendritic derivatives. It is hence clear that the number of the
guanidinium groups and not the molecular architecture of the
transporter is the predominant factor enhancing internalization.
In order to elucidate the effect of branching on cellular uptake,
Wender et al. [55], prepared a series of dendritic molecules bear-
ing 8 guanidinium groups on the external surface (Fig. 7). The
flexibility of the derivatives was adjusted by the introduction of
various chain length spacers between the branching points. TheFig. 7. Structure of dendritic molecules bearing 8 guanidinium groups at the emore flexible spacing between the branching points i.e. hexyl or
propyl led to derivatives exhibiting enhanced cell internalization.
It is interesting to note that these dendritic compounds surpassed
the most effective linear analogue, i.e. R9.
In order to investigate the translocational properties of com-
mercially available dendrimers such as poly(propylene imine)
dendrimers (DAB), a series of different generation of guanidi-
nylated dendrimeric derivatives was prepared and their ability
to cross model liposomal membranes consisting of phosphati-
dylcholine (PC), cholesterol (Chol) and dihexadecyl phosphate
(DHP), at PC:Chol:DHP 19:9.5:1 molar ratio, was assessed [12].
DHP molecules bear the phosphate groups necessary for the in-
teraction with the complementary guanidinium groups of the den-
drimeric derivatives.
The effect of the degree of surface guanidinylation on trans-
location properties was evaluated employing a fourth generation
poly(propylene imine) dendrimer with 32 surface amino groups
(DAB32). Five dendrimeric derivatives were prepared bearing 6,
12, 18, 26 and 32 guanidinium groups. Partially guanidinylated
dendrimers were quantitatively interacted with propylene oxide
for replacing the toxic amino groups in order to fit for in vitro and
in vivo experiments. Their ability to cross the liposomal bilayer
was studied employing FITC-labeled dendrimeric derivatives
which were allowed to interact with small unilamellar liposomes.
The results demonstrated the enhanced translocation ability of
the derivatives bearing 6, 12 and 18 guanidinium groups. These
derivatives possessed the necessary number of guanidinium
groups to achieve effective binding with the phosphate groups of
the lipids present in the bilayer, as well as an appropriate balance
between hydrophilic and hydrophobic surface groups in order to
form non-polar complex able to penetrate the liposomal bilayer.
Thiswas further confirmed by the fact that the non-guanidinylated
as well as highly guanidinylated derivatives had no transloca-
tional ability. Complete binding and subsequent formation of the
non-polar complex are not favored for the highly guanidinylated
dendrimeric derivatives.xternal surface with varying chain lengths between the branching points.
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on dendrimer generation and surface functionalization was also
studied. Specifically, third and fourth generation poly(propylene
imine) dendrimers (DAB16 and DAB32 respectively) with the
same degree of surface guanidinylation were compared. Initially,
the surface groups of dendrimers were partially acetylated while
the remaining amino groups were subsequently guanidinylated,
leading to derivatives possessing an appropriate balance bet-
ween hydrophilic and hydrophobic groups. Furthermore, in
order to investigate the effect of the spacer on the dendrimers
ability to cross the liposomal bilayer, fully functionalized den-
drimeric derivatives bearing a short spacer between the gua-
nidinium group and the surface amino group were prepared
(Fig. 8). When acetylated and guanidinylated dendrimers were
employed, the appropriate proportion of hydrophilic and
hydrophobic groups eliminated the effects attributed to den-
drimers size as far as their ability to cross the lipid bilayer of
small unilamellar liposomes is concerned. For the derivatives
bearing a short spacer, only the third generation dendrimeric
derivative showed efficient translocation. In this case the re-
latively small size of the third generation dendrimeric derivative
along with the spacer flexibility secured the formation of the
appropriate non-polar complex which subsequently crossed the
liposomal bilayer. Conversely the spacer flexibility could not
compensate with the increased size of the fourth generation
dendrimeric derivative, leading to insufficient charge neutraliza-
tion and therefore no translocational ability [56].
From these results it became evident that several structural
characteristics affecting the penetrability of the linear analogues
also apply to the dendritic architectures. Specifically, the degree
of guanidinylation remained a crucial structural feature, and it
was found that weak-to-medium guanidinylated dendrimers
translocated across the liposomal bilayer while highly guani-Fig. 8. Reaction scheme for the preparation ofdinylated analogues exhibited reduced penetrability. Moreover,
the appropriate balance between hydrophilic and hydrophobic
groups is significant since the interaction of the guanidinium
with the phosphate group leads, due to the spherical structure
of dendrimers, to partial charge neutralization but certainly
reduced hydrophilicity. Thus enhanced hydrophobicity, intro-
duced by the presence of hydrophobic groups on the den-
drimeric surface, is certainly an essential property for allowing
guanidinylated dendritic polymers to cross the lipid bilayer. It
has to be noted that the adaptive solubility behaviour exhibited
by dendritic polymers is not only attributed to anion neu-
tralization [12–14] or hydrophobic groups introduction on den-
drimers surface [56] but it is also an intrinsic property of the
dendritic polymers themselves. Specifically depending on the
polarity of the medium, dendritic polymers, through conforma-
tional change, expose either their polar or their non-polar
portion and therefore become soluble in solvents of differing
polarity [13].
Based on the above results the following mechanism (Fig. 9)
on the transport of guanidinylated dendrimers to liposomal mem-
branes can be proposed [12]; the process may be assumed to
simulate transport analogous to that in biological cells. According
to this mechanism, guanidinium groups first adhere to liposomal
membrane following their interaction with the negatively charged
phosphate group. Strong binding is induced bymultivalent effects
[25,26,57]. Due to charge neutralization of the adhered gua-
nidinylated dendrimers they become less polar and therefore
susceptible to enter the hydrophobic bilayer. Synergistically to
charge neutralization the adaptive solubility behaviour (“chame-
leon behaviour”) of the dendrimers starts functioning, rendering
the dendritic polymers even more hydrophobic and consequently
appropriate to be transported through the hydrophobic liposomal
membrane. This is in agreement with the described experimentalfunctional DAB dendrimeric derivatives.
Fig. 9. Proposed mechanism for dendrimer translocation across model liposomal membranes.
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dendrimers are transported through the liposomal membrane and
are solubilized in their aqueous core.
4. Multicompartmentalization induced by the interaction of
guanidinylated liposomes with their complementary
analogues
Organization of liposomal lipids [9], multivalency [25,26]
and combined electrostatic forces with bidentate hydrogen-
bonding between guanidinium and phosphate groups induces
strong binding of complementary liposomes. The subject of mole-
cular recognition of complementary liposomes has been thor-
oughly investigated by Lehn et al. [58], Paleos et al. [15,59–63]
and reviewed [64].
Following a strong liposomal adhesion by which the com-
plementary liposomes are simply conjoined with retention of their
inner compartments they subsequently merge by fusion sharing a
common inner compartment [65,66]. A sequence of processes
gives rise to the mixing of the aqueous content of liposomes, with
or without leakage or rupture of the fused vesicles. The com-
partments may remain intact or products of liposomal fusion may
be obtained, further reacting and leading to the formation of
multicompartment systems. In the examples that will be discussed
we will primarily highlight the property of multicompartmentaliza-tion since this is the one leading to multicompartment systems
formation.
The term “multicompartmental aggregate” was coined by
Zasadzinski's group [67] for aggregates originating from mole-
cular recognition of liposomes mediated by biotin–streptavidin
complex formation. A multi-stage procedure was proposed, in
which the key step was molecular recognition between comple-
mentary moieties whereas the final step involved an unrolling of
cochleate cylinders (multilamellar lipid tubules) bound to lipo-
somal aggregates, which led to the encapsulation of the latter
within the bilayer of the cylinders. In this manner, multicompart-
ment systemswere formed. In connectionwithmulticompartment
systems formation, it should be mentioned that encapsulation of
liposomes and colloidal particles was also achieved by a pro-
cedure based on cochleate cylinders with elimination of the
specific recognition steps. Thus, in a recent work [68], when Ca2+
was added to liposomes of dioleoylphosphatidylserine (DOPS),
fusion resulted in the formation of multilamellar cochleate cy-
linders of anionic bilayers. In an optional step, small liposomes or
colloidal particles were subsequently added to the dispersion of
these cylinders. Subsequently, complexation of Ca2+ upon ad-
dition of EDTA results in an unrolling of the cylinders and
reclosure of the bilayers. This process leads to the formation of
micrometer-sized DOPS giant liposomes which encapsulate the
added small liposomes or colloidal particles. It should be noted
Fig. 11. Phase-contrast optical microscopy image of a liposomal aggregate
obtained after mixing complementary liposomes. The bar in the upper-left
corner indicates 5 μm.
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the presence of cochleate cylinders is the critical step for the
formation of multicompartment systems.
Triggered by the above results on multicompartment sys-
tems formation, induced by complicated molecular recognition
processes [67], we were led to carefully observe the nature and
structure of aggregates obtained by molecular recognition expe-
riments between liposomes [15,59–63]. This aimed at investigat-
ing whether the aggregates obtained exhibit multicompartment
structures and, if this is the case, to uncover factors triggering or
inducing their formation.
For molecular recognition between liposomes to occur their
membrane is usually tailored by incorporating cholesterol, protec-
tive coating and indispensably recognizable groups. A model of
such an interacting complementary pair of liposomes is shown
in (Fig. 10) while examples on molecular recognition between
liposomes are discussed below.
Unilamellar mixed liposomes of about 100 nm diameter were
prepared [59] consisting basically of phosphatidylcholine (PC),
and cholesterol (Chol). For accomplishing molecular recog-
nition of these liposomes, one type of liposomes incorporated di-
n-hexadecylphosphate (DHP), while the other 1-[4-(dihexade-
cylcarbamoyl)butyl]guanidinium p-toluenesulfonate (DBG).
The strong binding between DHP and DBG moieties has al-
lowed experiments to be performed at low molar ratios of these
lipids relative to PC (molar ratio PC/DGB and PC/DHP=19:1).
Cholesterol was also incorporated in the liposomal membrane at
various concentrations ranging from 10% to 50% molar with
respect to PC simulating the cell membrane composition. The
so-prepared liposomes interacted spontaneously providing large
aggregates which were possible to observe by optical micro-
scopy. As concluded from their dimensions, fusion follows
initial adhesion leading to large liposomes, which in certain
cases encapsulate smaller ones. These structures exhibit a kind
of compartmentalization, which very primitively mimic the
compartments present in biological cells (Fig. 11).Fig. 10. Schematic representation of a multifunA significant outcome of this work, indirectly related to
compartmentalization is that cholesterol incorporated in these
liposomes appreciably enhances their molecular recognition
effectiveness. The molecular recognition enhancement, which
was observed at cholesterol concentrations ranging from 10% to
50% molar with respect to PC, was attributed to the structural
features of lipid–cholesterol bilayers. This finding was rationa-
lized on the basis of cholesterol's effect upon themolecular order
of the lipid bilayer according to a widely accepted phase diagram
[69–73]. According to this diagram, at the temperature range in
which these experiments were performed and at cholesterol
concentrations higher than 25% molar with respect to PC, the
liquid-ordered phase is formed. The fact that this phase is fluid,
from the viewpoint of lateral disorder and diffusion, is sig-
nificant for the molecular mobility of the recognizable mole-
cules. On the other hand, since the recognizable lipids are
incorporated at a low molar ratio (1:19), their presence does not
appreciably perturb the molecular organization of the PC–Chol
bilayer and therefore, the interacting moieties encounter the
previously mentioned organized environment permitting their
mobility. Apparently, molecular organization combined withctional complementary pair of liposomes.
Fig. 13. Phase-contrast optical microscopy images of liposomal aggregates after
mixingPEGylated complementary unilamellar liposomes. Their sizes correspondwith
the size distribution observed by DLS. The bar in the lower-left corner indicates 5 μm.
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ordered phase, results in a more enhanced association of the
liposomes. The enhancing role of cholesterol in liposomal asso-
ciation, observed by microscopic and light scattering studies,
was quantitatively established [59] by Isothermal Titration Mi-
crocalorimetry (ITC). The role of cholesterol in liposomal
recognition is also evident from the reaction rates, which were
determined by (ITC) experiments. Assuming single-exponential
kinetics, the reaction rates (k) become approximately 4 times
faster in the presence of cholesterol.
Extending the previous study, the inhibitory role of the protec-
tive polyethylene glycol (PEG) coating on molecular recognition
was investigated [15,60], employing liposomes based on hy-
drogenated PC and cholesterol and incorporating recognizable
moieties on their surface. One type of liposomes incorporated
DHP, whereas their complementary counterparts contained either
octadecylguanidine hydrochloride (ODG), N-[3-(octadecyla-
mino)propyl]guanidine hydrochloride (ODPG), or N-[3-(diocta-
decylamino)propyl]guanidine hydrochloride (DOPG) (Fig. 12).
With the application of the two latter guanidinylated lipids, the
role of the propylene spacer on the recognition effectiveness of
liposomes was assessed. Due to the presence of the spacer, the
guanidinium group protrudes from the liposomal interface and
therefore its interaction with the complementary phosphate group
is facilitated. PEG coating of molecular weight 5000 was intro-
duced on the surface of liposomes through the incorporation of a
varying number of PEGylated cholesterol molecules in the lipo-
somal membrane. This is a convenient strategy for the attachment
of the PEG at the liposomal surface in which the cholesterol
moiety is effectively anchored inside the liposomal membrane.
Following mixing of the complementary liposomes multicom-
partment aggregates were observed (Fig. 13) by phase-contrast
microscopy while their size was confirmed by dynamic light
scattering (DLS).
The fusion of complementary liposomes occurs under a non-
leaking process involving lipid mixing as it was established by
calcein entrapment and Resonance Energy Transfer experi-
ments [15]. The thermodynamic parameters correlate with theFig. 12. Structures of guprocesses of aggregation and fusion. Thus the interactions of
non-PEGylated liposomes consistently involve exothermic
processes of much higher enthalpic content compared to the
PEGylated counterparts. Thus, for the pairs [PC:Chol:ODPG]–
[PC:Chol:DHP] and [PC:Chol:ODG]–[PC:Chol:DHP], the ΔΗ
values are −5.7 and −3.0 Kcal/mol respectively, while for the
PEGylated liposomes (5% PEG relative to cholesterol) the ΔΗ
values are −3.8 and −1.1 Kcal/mol respectively.
Modeling the interaction of drug-loaded liposomes with
cells the interaction of loaded unilamellar with multilamellaranidinylated lipids.
Fig. 14. Phase-contrast optical microscopy image of a liposomal aggregate after
mixing samples of unilamellar and multilamellar complementary liposomes.
The bar in the upper-left corner indicates 5 μm.
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of liposomes were the same as in the previous experiment [61].
Nevertheless, one type of liposomes of the interacting comple-
mentary pair was now multilamellar. Highlighting on optical
microscopy studies, multicompartment systems were also ob-
served (Fig. 14), which were consistent, regarding their sizes,
with DLS measurements. This experiment further illustrates the
hypothesis [74] that molecular recognition, induced by the
interaction of surface guanidinium and phosphate groups, leads
to the formation of multicompartment systems.
Focusing on multicompartment systems formation, induced
by the interaction of guanidinium with phosphate groups, the
following mechanisms [74] may be proposed: Fusion between
liposomes is facilitated by the presence on their surface of
moieties that can molecularly recognize each other i.e. com-
plementary liposomes. In this manner liposomes of various
sizes are obtained (steps I and II, Fig. 15), which are generally
characterized as large unilamellar vesicles (LUV) and giant
unilamellar vesicles (GUV). According to Lehn et al. [58],Fig. 15. Proposed mechanism presenting the steps of formation of multicompartment lipowhich investigated an analogous complementary pair of lipo-
somes, adhesion leading to fusion does not take place between
giant liposomes, while a selective LUV-GUV adhesion does
occur leading to fusion (interaction step III, Fig. 14). This last
step can rationalize multicompartment systems formation, ac-
cording to which large liposomes are introduced in the interior
of giant liposomes through an engulfation and recognition step,
reminiscent of endocytosis. In the lower row of Fig. 15, the
images observed with phase-contrast microscopy are shown,
corresponding to the hypothesized in each step structures. It has
to be noted however, that giant liposomes are in general sus-
ceptible to various transformations which are triggered either by
the addition of appropriate chemicals or by temperature change,
as reviewed by Menger and Angelova [75]. Aggregates, analo-
gous to the ones presented in this review, have been prepared
and a mechanism of membrane fusion was proposed [76] jus-
tifying the incorporation of a smaller liposome to larger ones.
5. Concluding remarks
The role of guanidinium groups in peptides and dendritic
polymers is crucial in inducing transport through liposomal and
cell membranes; this behaviour is also dependent on the structural
features of the polymers. Furthermore the interaction of guani-
dinium groups located on the liposomal surface with phosphate
groups of complementary counterparts triggers a series of proces-
ses, involving reorganization of the membranous lipids leading to
the formation of multicompartment systems. These multicom-
partment systems were repeatedly observed even-though lipid
composition of the interacting liposomes was varied. Due to the
structural similarities between unilamellar liposomes and prokar-
yotic cells one may be led to a working hypothesis according to
which multicompartmentalization in eukaryotic cells resulted in a
fashion analogous to multicompartmentalization from the inter-
action of liposomes.somal structures in correspondence with phase-contrast optical microscopy images.
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